Comparison of Second-Generation Stents for Application in the Superficial Femoral Artery: An In Vitro Evaluation Focusing on Stent Design

被引:35
|
作者
Mueller-Huelsbeck, Stefan [1 ]
Schaefer, Philipp J. [2 ]
Charalambous, Nikolas [2 ]
Yagi, Hiroshi [3 ]
Heller, Martin [2 ]
Jahnke, Thomas [2 ]
机构
[1] Ev Luth Diakonissenanstalt Flensburg, Dept Diagnost & Intervent Radiol Neuroradiol, Acad Hosp Flensburg, D-24939 Flensburg, Germany
[2] Univ Hosp Schleswig Holstein, Dept Radiol, Kiel, Germany
[3] Terumo, Tokyo, Japan
关键词
superficial femoral artery; stent; nitinol; experimental study; finite element analysis; stent design; fatigue testing; stent fracture; compression; bending; torsion; NITINOL STENT; IMPLANTATION; FRACTURES; LESIONS; QUANTIFICATION; ANGIOPLASTY; DISEASE; TRIAL;
D O I
10.1583/10-3069.1
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: To examine and compare in an ex vivo study different nitinol stent designs intended for the superficial femoral artery (SFA) with regard to the appearance of fracture. Methods: Seven different 8-x40-mm nitinol stents were evaluated (Misago, Absolute, Smart, Luminexx, Sentinol, Lifestent NT, and Sinus-Superflex). Finite element analysis (FEA) was used for digitalized stent design comparison; the strain during stent movement was calculated for bending, compression, and torsion. Additional mechanical fatigue tests for bending (70 degrees), compression (40%), and torsion (twisted counterclockwise by 180 degrees) were performed up to 650,000 cycles or until a fracture was observed. Results:The FEA bending test showed that only the Misago, LifeStent, and Absolute stents presented no zones of high strain; in the torsion test, the Smart stent also had no zones of high strain. Macroscopic evaluation after mechanical bending indicated that the LifeStent performed the best (no stent fracture after 650,000 cycles). Misago and Absolute stents showed fractures at 536,000 cycles and 456,667 cycles, respectively (range 320,000-650,000 cycles). After compression and torsion testing, Misago showed no stent fracture after 650,000 cycles. The worst performing stent was Luminexx during all test cycles. Conclusion: The 7 SFA stents showed differences in the incidence of high strain zones, which indicates a potential for stent fracture, as demonstrated by the mechanical fatigue tests. Differences in stent design might play a major role in the appearance of stent strut fracture related to restenosis and reocclusion. J Endovasc Ther. 2010;17:767-776
引用
收藏
页码:767 / 776
页数:10
相关论文
共 50 条
  • [31] Three-year follow-up after treatment of bare-metal stent restenosis with first-generation or second-generation drug-eluting stents
    Almalla, Mohammad
    Schroeder, Joerg W.
    Pross, Verena
    Marx, Nikolaus
    Hoffmann, Rainer
    CORONARY ARTERY DISEASE, 2013, 24 (02) : 165 - 170
  • [32] Angioscopic comparison of arterial repair after second-generation drug-eluting stent implantation into vulnerable and stable coronary plaques
    Kawai, Kenji
    Ichikawa, Minoru
    Masuyama, Tohru
    Kijima, Yoshiyuki
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 221 : 855 - 858
  • [33] Comparison of First- and Second-Generation Drug-Eluting Stents in Saphenous Vein Grafts Used as Aorto-Coronary Conduits
    Costopoulos, Charis
    Latib, Azeem
    Naganuma, Toru
    Sticchi, Alessandro
    Chieffo, Alaide
    Figini, Filippo
    Carlino, Mauro
    Montorfano, Matteo
    Naim, Charbel
    Kawaguchi, Masanori
    Giannini, Francesco
    Colombo, Antonio
    AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (03) : 318 - 322
  • [34] In Vitro Comparison of the Fluoride Ion Release from the First- and Second-Generation Fluoride Varnishes
    Piesiak-Panczyszyn, Dagmara
    Watras, Adam
    Wiglusz, Rafal J.
    Dobrzynski, Maciej
    APPLIED SCIENCES-BASEL, 2023, 13 (12):
  • [35] Histological Evaluation of a Self-Expanding Stent-Graft 23 Months After Implantation in the Superficial Femoral Artery
    Ishihara, Takayuki
    Iida, Osamu
    Inoue, Katsumi
    Fujita, Masashi
    Masuda, Masaharu
    Okamoto, Shin
    Nanto, Kiyonori
    Kanda, Takashi
    Tsujimura, Takuya
    Sunaga, Akihiro
    Mano, Toshiaki
    Uematsu, Masaaki
    JOURNAL OF ENDOVASCULAR THERAPY, 2017, 24 (05) : 746 - 750
  • [36] Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation
    In Sook Kang
    Islam Shehata
    Dong-Ho Shin
    Jung-Sun Kim
    Byeong-Keuk Kim
    Young-Guk Ko
    Donghoon Choi
    Yangsoo Jang
    Myeong-Ki Hong
    Heart and Vessels, 2016, 31 : 1405 - 1411
  • [37] Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation
    Kang, In Sook
    Shehata, Islam
    Shin, Dong-Ho
    Kim, Jung-Sun
    Kim, Byeong-Keuk
    Ko, Young-Guk
    Choi, Donghoon
    Jang, Yangsoo
    Hong, Myeong-Ki
    HEART AND VESSELS, 2016, 31 (09) : 1405 - 1411
  • [38] Two-year clinical outcomes of patients with overlapping second-generation drug-eluting stents for treatment of long coronary artery lesions: comparison of everolimus-eluting stents with resolute zotarolimus-eluting stents
    Li, Xiao-tao
    Sun, Hao
    Zhang, Da-peng
    Xu, Li
    Ni, Zhu-hua
    Xia, Kun
    Liu, Yu
    Chi, Yong-hui
    He, Ji-fang
    Li, Wei-ming
    Wang, Hong-shi
    Wang, Le-feng
    Yang, Xin-chun
    CORONARY ARTERY DISEASE, 2014, 25 (05) : 405 - 411
  • [39] Comparison of Efficacy and Safety between First- and Second-Generation Drug-Eluting Stents in Patients with Acute Coronary Syndrome
    Ma, Yuan-Liang
    Tang, Xiao-Fang
    Yao, Yi
    Xu, Na
    Song, Ying
    Jiang, Ping
    Xu, Jing-Jing
    Wang, Huan-Huan
    Jiang, Lin
    Liu, Ru
    Zhao, Xue-Yan
    Chen, Jue
    Gao, Zhan
    Qiao, Shu-Bin
    Yang, Yue-Jin
    Gao, Run-Lin
    Xu, Ba
    Yuan, Jin-Qing
    CHINESE MEDICAL JOURNAL, 2018, 131 (12) : 1397 - 1405
  • [40] Biodegradable Polymer Drug-Eluting Stents Versus Second-Generation Drug-Eluting Stents for Patients With Coronary Artery Disease: An Update Meta-Analysis
    Wang, Yanyu
    Dong, Pingshuan
    Li, Ling
    Li, Xiaoling
    Wang, Hongyun
    Yang, Xuming
    Wang, Shaoxin
    Li, Zhuanzhen
    Shang, Xiyan
    CARDIOVASCULAR DRUGS AND THERAPY, 2014, 28 (04) : 379 - 385